Life Expectancy for People With Parkinson's Disease and Lewy Body Dementia
Synopsis: Mayo Clinic study provides answers for patients with Parkinsons disease, Lewy body dementia, multiple system atrophy with parkinsonism and Parkinsons disease dementia. The study used data from the Rochester Epidemiology Project, a collaboration of medical facilities in Minnesota and Wisconsin involving community members who have agreed to share their medical records for research. Parkinsonism was defined as having at least two of four signs: resting tremor, slowed movement, rigidity, and impaired reflexes to maintain posture and balance.
Faced with a serious disease, patients want to know the answer to a difficult question: "How long will I live?"
A new Mayo Clinic study in the JAMA Neurology has some answers for patients with Parkinson's disease, Lewy body dementia, multiple system atrophy with parkinsonism and Parkinson's disease dementia.
The population-based study found that patients with these diseases died about two years earlier than the general population. The highest risk of death was seen among patients with multiple system atrophy with parkinsonism at six years earlier. This high-risk group was followed by patients with Lewy body dementia, four years earlier; Parkinson disease dementia, 3½ years earlier; and Parkinson disease, one year earlier.
"As doctors, we want to be able to counsel our patients appropriately when they ask, 'What will happen to me?'" says Rodolfo Savica, M.D., Ph.D., lead author and a neurologist at Mayo Clinic. "Understanding long-term outcomes can help clinicians better inform patients and their caregivers about what to expect."
The study used data from the Rochester Epidemiology Project, a collaboration of medical facilities in Minnesota and Wisconsin involving community members who have agreed to share their medical records for research. The researchers reviewed data from 1991 through 2010. They compared 461 patients with these diseases to 452 patients in the general population - all in Olmsted County, Minnesota. Sixty percent of each group was men.
Patients who had synucleinopathies - diseases in which the brain accumulates abnormal amounts of the alpha-synuclein protein - included 309 with Parkinson's disease, 81 with Lewy body dementia, 55 with Parkinson's disease dementia, and 16 with multiple system atrophy with parkinsonism. Parkinsonism was defined as having at least two of four signs: resting tremor, slowed movement, rigidity, and impaired reflexes to maintain posture and balance.
Of the 461 patients with synucleinopathies, 316 or 68.6 percent died during follow-up. Of the 452 general population participants, 220 or 48.7 percent died during follow-up.
Cause of death also was compared. Among patients with synucleinopathies, neurodegenerative disease was the most frequent cause of death at 31.5 percent. Cardiovascular disease was the second most common cause of death at 15.7 percent. For the general population, cardiovascular disease was the most common cause of death at 25.5 percent.
"This helps understanding on how these diseases work," Dr. Savica says, noting that the paper is among the first comprehensive studies of the survival and cause of death of people with synucleinopathies, compared with the general population.
Study co-authors are Brandon Grossardt, M.S.; James Bower, M.D.; Eric Ahlskog, M.D., Ph.D.; Bradley Boeve, M.D.; Jonathan Graff-Radford, M.D., Walter Rocca, M.D.; and Michelle Mielke, Ph.D., all of Mayo Clinic. The study was supported by an award from the National Institute on Aging of the National Institutes of Health (grant AG 034676) and the Mayo Foundation for Medical Education and Research. The authors noted study limitations and conflict of interest disclosures.
This quality-reviewed article relating to our Longevity and Life Span section was selected for publishing by the editors of Disabled World due to its likely interest to our disability community readers. Though the content may have been edited for style, clarity, or length, the article "Life Expectancy for People With Parkinson's Disease and Lewy Body Dementia" was originally written by Mayo Clinic, and published by Disabled-World.com on 2017-05-18 (Updated: 2020-10-05). Should you require further information or clarification, Mayo Clinic can be contacted at mayo.edu. Disabled World makes no warranties or representations in connection therewith.
Share This Information To:
𝕏.com Facebook Reddit
Discover Related Topics:
Information, Citing and Disclaimer
Disabled World is an independent disability community founded in 2004 to provide disability news and information to people with disabilities, seniors, their family and/or carers. See our homepage for informative reviews, exclusive stories and how-tos. You can connect with us on social media such as X.com and our Facebook page.
Permalink: <a href="https://www.disabled-world.com/fitness/longevity/pd-lbd.php">Life Expectancy for People With Parkinson's Disease and Lewy Body Dementia</a>
Cite This Page (APA): Mayo Clinic. (2017, May 18). Life Expectancy for People With Parkinson's Disease and Lewy Body Dementia. Disabled World. Retrieved September 23, 2023 from www.disabled-world.com/fitness/longevity/pd-lbd.php
Disabled World provides general information only. The materials presented are never meant to substitute for qualified professional medical care, nor should they be construed as such. Funding is derived from advertisements or referral programs. Any 3rd party offering or advertising does not constitute an endorsement.